Neoplasms of Bone Tissue
📧 Sign up to get email alerts when something new happens for Neoplasms of Bone Tissue.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-18EMA Authorised: Yaxwer (denosumab) — Gedeon Richter Plc.
EMA authorised Yaxwer (denosumab) by Gedeon Richter Plc. for neoplasms involving bone tissue, including giant cell tumor of bone.
-
EMA approval · 2026-07-10EMA Authorised: Bomyntra (denosumab) — Fresenius Kabi Deutschland GmbH
EMA authorises Bomyntra (denosumab) for therapeutic areas including neoplasms of bone tissue and giant cell tumor of bone.
-
EMA approval · 2026-07-08EMA Authorised: Wyost (denosumab) — Sandoz GmbH
The EMA authorises Wyost (denosumab) by Sandoz GmbH for indications in Giant Cell Tumor of Bone and other bone neoplasms.